Lupin launches Ethacrynic Acid Tablets USP, 25 mg Medical Dialogues Bureau26 Feb 2020 3:27 PM ISTThe product would be manufactured at Lupin's Nagpur OSD facility, India.
Gilead's drug leads global race to find virus treatment Medical Dialogues Bureau26 Feb 2020 2:24 PM ISTBeijing | Tokyo: China will release results at the end of April from clinical trials of a Gilead Sciences drug that is emerging as a frontrunner in...
Beximco Pharma announces Commercial Agreement with Mylan in Bangladesh Medical Dialogues Bureau25 Feb 2020 4:28 PM ISTBeximco Pharmaceuticals Limited, manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, has announced the signing of a...
FDA authorizes marketing of the first genetic test for Fragile X Syndrome Medical Dialogues Bureau25 Feb 2020 2:09 PM ISTUS: The U.S. Food and Drug Administration has authorized marketing of the test to detect a genetic condition known as Fragile X Syndrome (FXS), the...
Novartis announces FDA and EMA filing acceptance of ofatumumab, for treatment of relapsing form of MS Medical Dialogues Bureau25 Feb 2020 1:03 PM IST"With ofatumumab, we underpin our relentless dedication to reimagining medicine for patients across the MS spectrum and will work closely with the...
BA/BE study applications have to be processed in 15 days: CDSCO Medical Dialogues Bureau25 Feb 2020 12:50 PM ISTNew Delhi: In order to streamline the applications process by various pharma companies, the CDSCO in its notice has recently mandated that BA/BE...
Aurobindo Pharma gets USFDA nod for Azithromycin 250 mg and 500 mg Medical Dialogues Bureau24 Feb 2020 2:22 PM ISTNew Delhi: Drug firm Aurobindo Pharma has received final approval from the USFDA to manufacture and market Azithromycin tablets, used for the...
USV not dominant player, hence no case: CCI dismisses petition by pharma wholesaler MD bureau24 Feb 2020 1:23 PM ISTNew Delhi: Noting that the drug firm USV does not seem to enjoy the dominant position in the portfolio of medicines that it sells and hence no case...
Coronavirus: Restrictions imposed on the export of medical equipment to China Medical Dialogues Bureau24 Feb 2020 12:29 PM ISTNew Delhi: India said some restrictions were imposed on export of certain medical equipment to China in view of their short supply within the country...
Solara Puducherry and Mangalore facilities complete USFDA Inspection with zero 483s observations Medical Dialogues Bureau24 Feb 2020 12:18 PM ISTChennai: Solara Active Pharma Science Limited (Solara), an active Pharmaceutical Ingredient provider has announced that the US Food and Drug...
Biocon's Insulin Manufacturing Facility in Malaysia Completes USFDA inspection with three observations Medical Dialogues Bureau24 Feb 2020 12:11 PM ISTMalaysia:Drug major Biocon recently informed about the USFDA inspection at its Insulin Manufacturing Facility in Malaysia, and that the agency issued...
USFDA approves Eli Lilly's Trulicity (dulaglutide) for reduction in MACE in type 2 diabetes patient Medical Dialogues Bureau23 Feb 2020 12:00 PM ISTNew indication reflects a distinct patient population in the REWIND study, including primary people with multiple cardiovascular risk factors but...
